Top Markets
#1 DogBull DogBull +107.47%
#2 MarsCoin MarsCoin +52.49%
#3 ADO Protocol ADO Protocol +51.98%
#4 Siacoin Siacoin +44.47%
#5 Ontology Gas Ontology Gas +26.06%
#6 Useless Coin Useless Coin +19.14%
#7 The Bitcoin Bull The Bitcoin Bull +15.13%
#8 Apertum Apertum +14.93%
#9 Nockchain Nockchain +12.84%
#10 Falcon Finance Falcon Finance +11.63%
Coin of the day
DogBull DogBull
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
BioAge Labs Inc. BioAge Labs Inc.

BioAge Labs Inc.

BIOA
Classement en actions #15445
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops... BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Prix de l'action
$9.34
Dernière synchronisation: 2026-08-31
Capitalisation boursière
$351.70M
Changement (1 jour)
-3.20%
Changement (1 an)
89.48%
Pays
US
Échange BioAge Labs Inc. (BIOA)

Catégorie

Healthcare
Bénéfices pour BioAge Labs Inc. (BIOA)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de BioAge Labs Inc., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour BioAge Labs Inc. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH